Quinazolines and thiazolidine-2,4-dions as SARS-CoV-2 inhibitors: repurposing,
Journal
RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657
Informations de publication
Date de publication:
22 Apr 2024
22 Apr 2024
Historique:
received:
16
03
2024
accepted:
18
04
2024
medline:
24
4
2024
pubmed:
24
4
2024
entrez:
24
4
2024
Statut:
epublish
Résumé
This paper presents an extensive analysis of COVID-19 with a specific focus on VEGFR-2 inhibitors as potential treatments. The investigation includes an overview of computational methodologies employed in drug repurposing and highlights
Identifiants
pubmed: 38655479
doi: 10.1039/d4ra02029d
pii: d4ra02029d
pmc: PMC11037030
doi:
Types de publication
Journal Article
Langues
eng
Pagination
13237-13250Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Arch Pharm (Weinheim). 2021 Feb;354(2):e2000279
pubmed: 33073374
Pain. 2021 Jan;162(1):243-252
pubmed: 33009246
Front Chem. 2021 Mar 24;9:628398
pubmed: 33842429
Crit Care. 2020 Jan 2;24(1):1
pubmed: 31898531
Molecules. 2021 Apr 20;26(8):
pubmed: 33923909
J Chem Theory Comput. 2012 Sep 11;8(9):3314-21
pubmed: 26605738
Curr Opin Struct Biol. 2023 Oct;82:102667
pubmed: 37544112
MedComm (2020). 2023 May 14;4(3):e254
pubmed: 37193304
Biochem Biophys Res Commun. 2004 Jun 4;318(3):719-25
pubmed: 15144898
Science. 2020 Jun 19;368(6497):1331-1335
pubmed: 32321856
Brief Bioinform. 2023 Mar 19;24(2):
pubmed: 36790845
J Comput Chem. 2004 Jul 15;25(9):1157-74
pubmed: 15116359
JMIR Bioinform Biotech. 2023 Jul 14;4:e43906
pubmed: 37485046
Pathogens. 2021 May 19;10(5):
pubmed: 34069460
J Mol Struct. 2020 Dec 15;1222:128878
pubmed: 32834113
Chin Med J (Engl). 2020 May 5;133(9):1051-1056
pubmed: 32149769
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Chem Sci. 2020 Nov 27;12(4):1433-1444
pubmed: 34163906
J Comput Chem. 2009 Dec;30(16):2785-91
pubmed: 19399780
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1697-1710
pubmed: 31537132
J Comput Aided Mol Des. 2017 Feb;31(2):201-211
pubmed: 28074360
Life Sci. 2020 May 1;248:117477
pubmed: 32119961
ACS Pharmacol Transl Sci. 2020 Nov 11;3(6):1330-1338
pubmed: 33344906
J Tradit Complement Med. 2022 Jan;12(1):16-34
pubmed: 34026584
Science. 2003 Jun 13;300(5626):1763-7
pubmed: 12746549
Int Immunopharmacol. 2021 Dec;101(Pt B):108257
pubmed: 34673299
Science. 2020 Apr 24;368(6489):409-412
pubmed: 32198291
J Biomol Struct Dyn. 2023 Nov;41(19):9267-9281
pubmed: 36399002
J Med Virol. 2020 Apr;92(4):418-423
pubmed: 31967327
J Mol Biol. 2009 Jan 16;385(2):381-92
pubmed: 19041878
Pharmacol Res. 2023 Jan;187:106552
pubmed: 36403719
Sci Rep. 2022 Jan 25;12(1):1299
pubmed: 35079088
Signal Transduct Target Ther. 2020 Jan 3;5(1):1
pubmed: 32296011
Arch Pharm (Weinheim). 2021 Jul;354(7):e2000491
pubmed: 33788290
PLoS Biol. 2005 Oct;3(10):e324
pubmed: 16128623
J Chem Inf Model. 2011 Jan 24;51(1):69-82
pubmed: 21117705
Nature. 2020 Jun;582(7811):289-293
pubmed: 32272481
Microbes Infect. 2020 Mar;22(2):80-85
pubmed: 32087334
Nat Commun. 2023 Oct 13;14(1):6463
pubmed: 37833261
Lancet Rheumatol. 2020 Jul;2(7):e376-e379
pubmed: 32427161
Vacunas. 2022 May;23:S1-S13
pubmed: 34876891
ACS Cent Sci. 2023 Mar 21;9(4):696-708
pubmed: 37122453
Nature. 1990 Oct 18;347(6294):631-9
pubmed: 2215695
Genes Dis. 2023 Jan 20;11(1):148-175
pubmed: 37588226
J Biomol Struct Dyn. 2022;40(19):8866-8893
pubmed: 33928870
Biol Pharm Bull. 2011;34(12):1785-8
pubmed: 22130231
Russ J Bioorg Chem. 2023 May 11;:1-7
pubmed: 37360794
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508